Two Biosimilars Approved in Europe for Autoimmune Disorders Two Biosimilars Approved in Europe for Autoimmune Disorders
The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn ' s disease.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 26, 2024 Category: Allergy & Immunology Tags: Pharmacist News Alert Source Type: news
Loss of Anti-TNF Treatment Response Common in Crohn's Disease
(MedPage Today) -- Approximately two-thirds of patients with Crohn's disease who initially responded to tumor necrosis factor (TNF) inhibitors lost response by the third year of treatment, a population-based observational study showed.
Fully 60... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 22, 2024 Category: Gastroenterology Source Type: news
Patients with suspected bowel disease could refer themselves for scans, saving time on long waiting lists
Currently, patients with suspected Crohn's disease or ulcerative colitis, known together as inflammatory bowel disease (IBD), have to see a GP before they can be referred to hospital for a diagnosis. (Source: the Mail online | Health)
Source: the Mail online | Health - April 21, 2024 Category: Consumer Health News Source Type: news
FDA OKs Sub-Q Vedolizumab for Crohn's Maintenance Therapy FDA OKs Sub-Q Vedolizumab for Crohn's Maintenance Therapy
Subcutaneous administration of vedolizumab is now approved for maintenance therapy in adults with moderate to severe active Crohn ' s disease after induction therapy with intravenous vedolizumab.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 19, 2024 Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news
Immune-Mediated GI Disease May Up Eating Disorder Risk Immune-Mediated GI Disease May Up Eating Disorder Risk
Researchers found a high prevalence of eating disorders in patients with major types of immune-mediated GI diseases, especially in pediatric patients diagnosed with ulcerative colitis.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 19, 2024 Category: Gastroenterology Tags: Gastroenterology Clinical Summary Source Type: news
Study IDs Risk Factors for Extraintestinal Manifestations of IBD
WEDNESDAY, April 17, 2024 -- Certain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations (EIMs) with inflammatory bowel disease (IBD), according to a study published online March 13... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2024 Category: Pharmaceuticals Source Type: news
Some Gut Bugs May Help Lower Your Cholesterol
WEDNESDAY, April 17, 2024 -- Changes in gut bacteria have been linked to a variety of different diseases, including type 2 diabetes, obesity and inflammatory bowel disease.Now, a new study indicates that gut bacteria also might play a role in a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 17, 2024 Category: General Medicine Source Type: news
TNF Inhibitors for IBD Linked to Kidney Function Declines
(MedPage Today) -- Anti-tumor necrosis factor (TNF) therapy for new-onset inflammatory bowel disease (IBD) was independently associated with progressive kidney function decline but not survival, a VA cohort study found.
Multivariable analysis... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - April 16, 2024 Category: Gastroenterology Source Type: news
Childhood Atopic Dermatitis Linked to IBD Risk Childhood Atopic Dermatitis Linked to IBD Risk
A prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 10, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
How Psychological Distress Affects GI Symptom Severity in UC How Psychological Distress Affects GI Symptom Severity in UC
Psychological distress predicts symptom severity and mental health-related quality of life in patients newly diagnosed with ulcerative colitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 9, 2024 Category: Consumer Health News Tags: Gastroenterology Source Type: news
Higher Vitamin D Levels Cut Bowel Resection Risk With IBD
WEDNESDAY, April 3, 2024 -- An increased serum level of 25-hydroxyvitamin D (25[OH]D) is independently associated with a lower risk for bowel resection with inflammatory bowel disease (IBD), according to a study published online March 25 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 3, 2024 Category: Pharmaceuticals Source Type: news
Upadacitinib Provides Rapid Relief in Crohn's Disease Upadacitinib Provides Rapid Relief in Crohn's Disease
Patients with Crohn ' s disease achieved rapid symptom relief with upadacitinib, including those with prior biologic failure.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 3, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
Scientists link certain gut bacteria to lower heart disease risk
Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well. In a study published in Cell, the team has identified specific species of bacteria that consume cholesterol in the gut and may help lower cholesterol and heart disease risk in people. (Source: World Pharma News)
Source: World Pharma News - April 2, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Hundreds of thousands of Crohn's patients will get a vital drug quicker to avoid drastic invasive surgery
Crohn's patients have been offered a drug called infliximab, which has been shown to reduce painful symptoms and limit severe complications. (Source: the Mail online | Health)
Source: the Mail online | Health - March 31, 2024 Category: Consumer Health News Source Type: news
Bristol Myers' Bowel Disease Drug Fails in Late-stage Study Bristol Myers' Bowel Disease Drug Fails in Late-stage Study
Bristol Myers Squibb said on Thursday its experimental drug to treat Crohn ' s disease, a chronic inflammatory bowel condition, did not help patients achieve disease remission...Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 28, 2024 Category: Gastroenterology Tags: Gastroenterology Source Type: news
